Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$62,128,962
-$18,180,554 QoQ
Shares Held
8,121,433
-1.7% QoQ
Ownership
9.67%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. REPL ranks #51 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in REPL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-04-30 | $383,065 | 157,965 | Shares | Sole | 2026-05-07 | |
| 2026-03-31 | $62,128,962 | 8,121,433 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $80,309,516 | 8,262,296 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,803,953 | 8,306,433 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $100,510,450 | 10,819,209 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $105,824,861 | 10,853,832 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $132,760,513 | 10,962,883 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $108,276,579 | 9,879,250 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $83,124,513 | 9,236,057 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $53,504,757 | 6,548,930 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $49,309,185 | 5,849,251 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $99,121,634 | 5,793,199 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $133,120,537 | 5,733,012 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $97,052,578 | 5,495,616 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $137,761,036 | 5,064,744 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $72,036,122 | 4,171,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $102,826,641 | 5,882,531 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $102,266,464 | 6,022,760 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $159,040,089 | 5,868,638 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $169,453,065 | 5,717,040 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $194,768,269 | 5,069,450 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $93,917,163 | 3,078,242 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $100,170,111 | 2,625,691 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,810,226 | 426,161 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,625,374 | 387,339 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||